key: cord-0751842-o68nde3u authors: Alghonemy, Wafaa Yahia; Helal, Mai Badreldin title: Systemic immune response development in Albino rats after retrograde instillation of COVID-19 vaccine to submandibular salivary gland: An experimental study date: 2022-03-22 journal: J Oral Biol Craniofac Res DOI: 10.1016/j.jobcr.2022.03.013 sha: 287e9932a200510561b0d36becce56b769b86ae8 doc_id: 751842 cord_uid: o68nde3u OBJECTIVE: This study aimed to investigate whether using the submandibular gland duct (SMD) as an alternative mucosal route for vaccine administration induced anti-COVID-19 specific immunity. MATERIAL AND METHODS: Forty rats were randomized equally into four groups; Group I: Rats did not receive any intervention. Group II: Rats were subjected to intramuscular (IM) injection of COVID-19 vaccine. Group III: Rats were subjected to ductal cannulation by retrograde instillation of sterile saline into right SMD. Group IV: Rats in this group who had 0.5 ml of COVID-19 vaccine retrogradely injected into the right SMD. Subsequently, rats were examined for anti-COVID-19 specific antibodies (IgG). Also, light microscopic observation of glandular changes and immunohistochemical staining for CD20 was performed. RESULTS: The obtained results demonstrated a significant increase in anti-COVID-19 IgG levels in all rats vaccinated via intraductal immunization (group IV) compared to group II. Histologically, ectopic follicles were found within the glandular lobules of the inoculated submandibular gland (SMG) in group IV. In addition, the nearby lymph node in group IV demonstrated reactive follicle characteristics in the form of activated secondary follicles with germinal centers (GCs). Immunohistochemically, CD20 was localized in group IV in GCs of the ectopic lymphoid tissue and the nearby lymph nodes while group I, group II, and III demonstrated negative immunoreactivity. CONCLUSION: The immune response demonstrated by intraductal SG immunization is generally more significant than that elicited by IM inoculation of the same vaccine. Forty rats were divided equally into four groups; Group I: Rats received no intervention. Group II: Rats in this group were subjected to intramuscular injection of COVID-19 vaccine. Group III: Rats in this group were subjected to retrograde instillation of sterile saline into right SMD via ductal cannulation. Group IV: Rats in this group were subjected to retrograde instillation of 0.5 ml of COVID-19 vaccine into right SMD. After that, rats were evaluated for anti-COVID specific antibodies (IgG). Also, light microscopic observation of glandular changes together with immunohistochemical staining for CD20 were done The obtained results showed a significant increase in anti-COVID-19 IgG levels that were highest in all rats vaccinated via intraductal inoculation (group IV) compared to group II. Histologically, the inoculated submandibular gland in group IV displayed ectopic follicles within the glandular lobules. Also, the nearby lymph node in group IV showed the features of reactive follicles, in the form of activated secondary follicles with germinal centers. Immunohistochemically, CD20 was localized in group IV in GCs of the ectopic lymphoid tissue and the nearby lymph nodes. While group I, group II, and III depicted negative immunoreactivity 1 Abstract: Objective: This study aimed to investigate whether using the submandibular gland duct (SMD) as an alternative mucosal route for vaccine administration induced anti-COVID-19 specific immunity. Material and methods: Forty rats were randomized equally into four groups; Group I: Rats did not receive any intervention. Group II: Rats were subjected to intramuscular (IM) injection of COVID-19 vaccine. Group III: Rats were subjected to ductal cannulation by retrograde instillation of sterile saline into right SMD. Group IV: Rats in this group who had 0.5 ml of COVID-19 vaccine retrogradely injected into the right SMD. Subsequently, rats were examined for anti-COVID-19 specific antibodies (IgG). Also, light microscopic observation of glandular changes and immunohistochemical staining for CD20 was performed. Interestingly, SGs are also reported to function as immune organs (3). Since they have some immune characteristics, such as the presence of dendritic cells, together with an extensive lymphoid tissue distribution. These lymphoid tissues represent the site of B cell activation and the inducer for cytotoxic T-lymphocytes (4) . In addition to the immune function and the well-known exocrine function, many researchers have demonstrated that SGs have an endocrine function (5,6) such as secretion from rodent SMG into the blood has been demonstrated for glucagon (7), EGF (8), NGF (9), renin (10), kallikrein (11) , and sialorphin (12, 13) . Additionally, parotid gland endocrine secretion has been confirmed for a protein complex originally extracted from bovine parotid glands (14) and amylase (15) . Consequently, SGs have dual exocrine and endocrine functions. Due to these distinct, diverse characteristics, some researchers used SGs as an optimal immunization site for vaccination via retrograde perfusion of the gland duct using a gene or vaccine (3, 16) . In an elegant study, Ponzio & Sanders (16) investigated SGs as an immunizing site using DNA or attenuated pathogen. They found that intraductal vaccination resulted Forty adult male albino rats aged between 8-10 weeks (200-250 grams). The sample size was calculated using StatCalc under Epi-info software with a two-sided confidence level of 95 % and a power of 80 % with a ratio of control: immunized is 1:1. Therefore, we have used ten rats per group. The rats were purchased and housed for two weeks and received a standard diet and water. They were kept in a 12-h light/dark cycle prior to the experimental procedures. These were performed at Oral Biology Laboratory, Oral Biology Department, Faculty of Dentistry, Tanta University. Animals were randomly divided into four groups (n=10) as follows: Group 1: (Control) rats did not undergo any intervention. Group II (IM vaccine) rats were subjected to IM injection of 0.5 ml of a single dose of COVID-19 vaccine BIBP. Group III (Intraductal saline) rats were subjected to retrograde instillation of 0.5 ml of sterile physiological saline into right SMG via ductal cannulation. Group IV (Intraductal vaccine) rats in this group were subjected to retrograde instillation of 0.5 ml of COVID-19 vaccine BIBP into the right SMG via ductal cannulation. All animal experiments were conducted in accordance with the ARRIVE guidelines and were conducted after getting permission from the Internal Research The animals were anesthetized via intraperitoneal injection with Ketamine hydrochloride 10% (Sigma-Aldrich Pty Ltd) with xylazine hydrochloride 2% (Sigma-Aldrich Pty Ltd) at a dosage of 0.06 ml/g & 0.03 ml/g, respectively (18) . The duct cannulation was performed according to the following schedule (19): The rats were subcutaneously injected with 1μl/g bodyweight of 0.5 mg/ml atropine sulfate monohydrate (Sigma-Aldrich Pty Ltd) to inhibit the salivary secretions. Afterward, the rats were placed in the ventral position, the maxillary incisors were bolted on a metal wire, and the mandibular incisors were hooked on an elastic string. Serum samples were collected 28 days after vaccine injection to test for anti-COVID-19-specific IgG antibodies. Under ether anesthesia (Sigma-Aldrich Pty Ltd), blood samples were collected from the jugular vein of rats in all groups into centrifuge tubes. Blood was allowed to clot at room temperature for about one hour before centrifuging at 3000 rpm for 10 min. Serum was separated and kept at −20 °C prior to analysis for antigen-specific ELISA (20). At the end of the experiment (at day 28), all the rats were treated with an overdose of ketamine anesthesia and sacrificed, and then SMG tissues were dissected and removed instantly for light microscopic (LM) investigation. Sample preparation was performed according to Bancroft et al. (21) . For three days, the dissected tissues were kept and fixed in 10% neutral buffered formalin at 4•C. After fixation, they were embedded in paraffin, and serial tissue sections of 4μm thickness were obtained from all groups. Each group received two sets of tissue J o u r n a l P r e -p r o o f sections. One was stained with hematoxylin and eosin (H&E) for histopathological examination. The second was loaded on positively charged glass slides for immunohistochemical analysis to detect CD20 markers (cluster of differentiation 20). It is a transmembrane glycoprotein predominantly expressed on the surface of B cells. Serum analysis data were expressed as mean ± SD using SPSS (Statistical Package for Social Sciences) 22.0 software. One-way analysis of variances (ANOVA) was used to compare all experimental groups. Then, Tukey's honestly significant difference (HSD) test was used to determine if there was a significant difference between the various pairs of means. The level of significance was determined at a Pvalue < 0. The bodyweight of all experimental rats was recorded throughout the experiment. It was observed that group II, group III, and group IV demonstrated no changes in body weight when compared to group I (control group). The obtained results demonstrated a significant increase in anti-COVID-19 IgG levels in group IV (intraductal vaccine), which had the highest antibody titer compared to group I (control group), group II (IM vaccine), and group III (intraductal saline). Also, group II exhibited significant anti-COVID-19 IgG levels than group I and group II. Nevertheless, the anti-COVID-19 IgG levels were insignificant in groups I and III (Table. 1 ). Also, the nearby lymphoid tissue appeared normal in the form of primary lymphoid aggregates ( Fig. 1 and Fig.2) . Similarly, in group II, SMG parenchymal elements and the closely associated lymph node demonstrated normal structures (Fig. 2) . • Group IV: The SMG of group IV (intraductal vaccine) SMG displayed ectopic lymphoid tissue with GCs. Also, the nearby lymph node displayed reactive follicle characteristics in the form of activated secondary follicles with GCs (Fig. 3 ). In both groups (I, II, and III), immunohistochemical localization of CD20 as a marker for B cells in the nearby SMG lymph nodes revealed negative immunoreactivity in both groups (I, II, and III) compared to group IV (Fig. 4 a-b) . Group IV displayed strong immunoreactivity to CD20 in the active lymphoid GCs in the nearby lymph nodes and the ectopic lymph nodes located within the SMG lobules ( Fig. 4 c-d and Fig. 5 ). Mucosally administered vaccines have gained significant attention due to their ease of administration and their ability to protect multiple mucosal sites as well as systemic sites. Furthermore, when dealing with pathogens, particularly viruses, effective immunization approaches are required to understand the defense mechanisms in the tissues, which is a crucial issue in vaccine development (4). Traditionally, most vaccines are administrated parentally via injection, such as IM and subcutaneous injections. Interestingly, these immunization sites can induce humoral immune responses in systemic (e.g., spleen, blood, and draining lymph nodes) but not in mucosal compartments, the immune response at mucous membranes (e.g., Interestingly, the main histological and immunohistochemical findings in this study included the following: First, GCs, a specialized microstructure that forms in secondary lymphoid tissues such as lymph nodes, produce long-lived antibody-secreting plasma cells and B cells, protecting against reinfection. Also, GCs allow interactions between T and B cells that are critical for developing most humoral immune responses that can be protective in response to vaccination or infection (29) . Second, ectopic GCs are located within the SMG lobules. This finding is consistent with previous studies, which found that ectopic GCs could be formed in nonlymphoid tissue such as SGs (30) (31) (32) . In addition, Pitzalis et al. (33) There are several limitations to this study. The main limitation of this study is the lack of previous research studies on the same topic. Additionally, the small mouth opening of some rats caused difficulty in detecting SMD opening. Over and above, some limitations for the future suggestions based on the results of this study include patient agreement for SMD injection instead of IM, SG diseases that may avert this route of administration, and SG delivery technology that would necessitate more workers time of a trained medical professional than IM vaccination by the needle. J o u r n a l P r e -p r o o f The strength of immune response bestowed by intraductal SG vaccination is generally more significant than that d elicited by IM vaccination with the same vaccine. Therefore, further studies should be conducted in the future, focusing on this novel approach and detecting the mucosal immune response associated with this approach. None. We wish to confirm no known conflicts of interest associated with this publication. There has been no significant financial support for this work that could have influenced its outcome. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Light micrographs display immunohistochemical staining of CD20 expression in lymph nodes associated with SMG. a. Group I (control) shows negative CD20 immunostaining. b. Group II (intramuscular vaccine) shows negative CD20 immunostaining in the lymphoid follicles (branched arrow). c. Group III (intraductal saline) displays negative CD20 immunostaining. Light micrographs display immunohistochemical staining of CD20 expression in the newly formed ectopic lymphoid tissue in group IV (Intraductal vaccine). a. Reveals ectopic lymphoid follicles (LN) within the SMG lobules (S). Notice, the LN displays strong immunostaining of CD20 within the GCs. b. Displays ectopic secondary lymphoid tissue with GCs (boxed area) with inset reveals higher magnification of the boxed area viewing positive B cell membranous immunostaining, (CD20 immunostaining counterstain with Mayer's hematoxylin. a x100, bx100, inset x400). J o u r n a l P r e -p r o o f Highlights: • Salivary gland intraductal vaccination developed a systemic immune response. • High antibody levels are obtained via salivary glands intraductal vaccination. • Salivary glands are a potential mucosal route for administering vaccines. Clinical features of patients infected with 2019 novel coronavirus in Wuhan Salivary gland immunization via Wharton's duct activates differential T-cell responses within the salivary gland immune system Salivary glands act as mucosal inductive sites via the formation of ectopic germinal centers after site-restricted MCMV infection Induction of secretory immunity and memory at mucosal surfaces. Vaccine CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE Parotid Secretory Granules : Crossroads of Secretory Pathways and Protein Storage The parotid gland is the main source of human salivary epidermal growth factor Salivary gland hyperglycemic factor: an extrapancreatic source of glucagon-like material. Science (80-) Exocrine and endocrine secretion of renin and epidermal growth factor from the mouse submandibular glands Nerve growth factor in mouse serum and saliva: Role of the submandibular gland Vast release of submaxillary mouse renin to saliva after stimulation with cholinergic, β-adrenergic but especially α-adrenergic agonists Exocrine and endocrine release of kallikrein after reflex-induced salivary secretion Targets for SMR1-pentapeptide suggest a link between the circulating peptide and mineral transport Novel genes and hormones in salivary glands: From the gene for the submandibular rat 1 protein (SMR1) precursor to receptor sites for SMR1 mature peptides The internal secretion of salivary gland Effects of secretory nerve stimulation on the movement of rat parotid amylase into the circulation The salivary gland as a target for enhancing immunization response Background document on the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group ( CNBG ) Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats Cannulation of the mouse submandibular salivary gland via the Wharton's duct Curcuminphospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats Bancroft's Theory and Practice of Histological Techniques Saliva-the defender of the oral cavity Salivary glands: novel target sites for gene therapeutics Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responses Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands Protective MCMV immunity by vaccination of the salivary gland via Wharton's duct: Replicationdeficient recombinant adenovirus expressing individual MCMV genes elicits protection similar to that of MCMV Regulation of the germinal center response Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by Lselectin/PNAd, α4β1 integrin/VCAM-1, and LFA-1 adhesion pathways Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome Ectopic lymphoid-like structures in infection, cancer and autoimmunity Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers A unique cell surface antigen identifying lymphoid malignancies of B cell origin Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action The who, how and where of antigen presentation to B cells Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts Extrafollicular antibody responses Distinct cellular pathways select germlineencoded and somatically mutated antibodies into immunological memory Targeted salivary gland immunization with plasmid DNA elicits specific salivary immunoglobulin A and G antibodies and serum immunoglobulin G antibodies in mice Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland Memory B cells: Effectors of long-lived immune responses Breadth of antibody responses during influenza virus infection and vaccination Salivary gland genetic vaccination: A scalable technology for promoting distal mucosal immunity and heightened systemic immune responses Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands Authors acknowledge sincerely the support given by Faculty of Dentistry, Tanta University for using Oral Biology research laboratory and animal housing unit.